THE Australian Self-Medication Industry has highlighted a new study which is seeking participants to investigate the impact of the removal of over-the-counter codeine on 01 Feb 2018.
The research is being conducted by scientists from the University of Tasmania and the University of NSW, and will involve a web-based survey to follow patients over a 12-month period to explore the impact the new regulation on access to codeine has on their use of codeine-containing medicines, pain management, their mental and physical health, and their use of health providers such as GPs and pharmacies.
Regular consumers of codeine-containing medicines who are over 18, live in Australia and are not currently being treated for codeine dependence are invited to apply to take part in the study.
The online survey will be required to be completed four times over a 12 month period, and for the first survey participants have the opportunity to win one of twenty $100 vouchers, with a $20 reimbursement for completing each of the other three surveys.
Participant details will be deidentified, and no individual data will be publshed, with more information on how to register and a brief screening survey now available at www.utas.edu.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Nov 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Nov 17
